FEATURED
Market Minute: Regime change in rates rolls higher
Sep 2, 2026 BY Joseph Brusuelas
Investors are pushing up rates as inflation rises, nations add to their debt and as geopolitical risk continues unabated. ... READ MORE >Main Content
Insights from FDA complete response letters: Preventing costly drug approval delays

FDA’s complete response letters reveal the importance of addressing issues early for biopharma companies. … READ MORE >
From AI-assisted discovery to purchase: Closing the consumer trust gap
By Peter Ramer

The gap between AI-assisted research and AI-driven purchasing represents one of retail’s biggest opportunities. … READ MORE >
India’s GDP grew 7.8% in second quarter, defying global headwinds
By Prachi Jhamb

We’re raising our full-year forecast toward 7% growth for fiscal 2026-27, above the RBI’s revised 6.7% projection. … READ MORE >
5 things to know in life sciences: Week of Aug. 24, 2026
By Katherine Powers and Max Stanyard

Each week we highlight five things affecting the life sciences industry. Here’s the latest. … READ MORE >
